Quality of life, symptom profile and clinical efficacy of second-line treatment with dasatinib in patients with imatinib-resistant or -intolerant chronic myeloid leukemia: results of 2-year follow-up

Bibliographic Details
Main Authors: T. I. Ionova, T. P. Nikitina, E. G. Lomaia, G. B. Kuchma, E. R. Machyulaytene, E. I. Usacheva, T. V. Shnaider, A. Yu. Rodionova, K. A. Kurbatova
Format: Article
Language:Russian
Published: ABV-press 2015-10-01
Series:Онкогематология
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/150